Simplified quantification of [
Dopamine transporter
Parkinson’s disease
[18F]FE-PE2I
reliability
specific binding ratio
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
pubmed:
22
9
2020
medline:
31
7
2021
entrez:
21
9
2020
Statut:
ppublish
Résumé
Quantification of dopamine transporter (DAT) availability with [
Identifiants
pubmed: 32955955
doi: 10.1177/0271678X20958755
pmc: PMC8138335
doi:
Substances chimiques
(E)-N-(3-iodoprop-2-enyl)-2beta-carbofluoroethoxy-3beta-(4'-methyl-phenyl) nortropane
0
Nortropanes
0
Radiopharmaceuticals
0
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1291-1300Références
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):424-38
pubmed: 17968545
N Engl J Med. 2004 Dec 9;351(24):2498-508
pubmed: 15590952
J Nucl Med. 2012 Jan;53(1):154-63
pubmed: 22159160
Nucl Med Biol. 2012 Feb;39(2):295-303
pubmed: 22033024
Neurology. 2007 Oct 9;69(15):1480-90
pubmed: 17881719
Neurology. 2014 May 20;82(20):1791-7
pubmed: 24759846
J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):314-9
pubmed: 9527140
J Nucl Med. 2015 May;56(5):714-20
pubmed: 25791993
J Nucl Med. 2011 Jan;52(1):132-9
pubmed: 21189414
Brain. 2011 Nov;134(Pt 11):3146-66
pubmed: 21810889
J Parkinsons Dis. 2019;9(3):553-563
pubmed: 31306141
Ann Neurol. 2010 Jun;67(6):715-25
pubmed: 20517933
J Nucl Med. 2012 Jul;53(7):1065-73
pubmed: 22689927
J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52
pubmed: 2841426
Ann Neurol. 2000 Jun;47(6):804-8
pubmed: 10852547
Eur J Nucl Med Mol Imaging. 2013 Jan;40(2):228-37
pubmed: 23076621
Brain. 1999 Aug;122 ( Pt 8):1449-68
pubmed: 10430831
EJNMMI Res. 2018 Nov 15;8(1):100
pubmed: 30443684
Mov Disord. 2003 Oct;18 Suppl 7:S71-80
pubmed: 14531049
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):443-50
pubmed: 19838702
N Engl J Med. 1988 Apr 7;318(14):876-80
pubmed: 3352672
J Nucl Med. 2016 Oct;57(10):1529-1534
pubmed: 27230923
J Cereb Blood Flow Metab. 1993 Jan;13(1):24-42
pubmed: 8380178
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Mov Disord. 2001 Jul;16(4):608-15
pubmed: 11481683
Lancet Neurol. 2009 Dec;8(12):1128-39
pubmed: 19909911
Parkinsonism Relat Disord. 2014 Aug;20(8):793-9
pubmed: 24894118
Neuroimage. 2017 Jul 15;155:344-353
pubmed: 28419852
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1913-1926
pubmed: 31776633
J Strength Cond Res. 2005 Feb;19(1):231-40
pubmed: 15705040
Parkinsonism Relat Disord. 2005 Dec;11(8):475-84
pubmed: 16257254
Sci Transl Med. 2018 Aug 15;10(454):
pubmed: 30111645
Neurology. 2001 Dec 11;57(11):2089-94
pubmed: 11739831
J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):294-8
pubmed: 12588911
Mov Disord. 2019 Oct;34(10):1430-1432
pubmed: 31769089
Q J Nucl Med Mol Imaging. 2012 Feb;56(1):68-82
pubmed: 22460161
Neuroimage. 1996 Dec;4(3 Pt 1):153-8
pubmed: 9345505
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
Synapse. 2009 Oct;63(10):871-80
pubmed: 19562698
J Parkinsons Dis. 2019;9(1):31-61
pubmed: 30400107